Baricitinib for Patients With Intracerebral Hemorrhage
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT06737705
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Registry
-
NCT06737705
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06737705. Randomized; single masking; primary purpose treatment. Start 2025-01-01 (actual); primary completion 2025-08-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Baricitinib for Patients With Intracerebral Hemorrhage
- Acronym
- BRIGHT
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- Baritinib
- Lead sponsor
- De-zhi Kang
- Collaborator
- Fujian Medical University
- Collaborator
- Tianjin Medical University General Hospital
Record details
- Record id
cardio:ct-nct06737705- Content hash
846b4f3b82afd1a11884dfb5fc4fcf0ea0cc7f6fbb184279aaeda35ddeab2794